Discovery could lead to 'next-gen' vaccines

April 08, 2012 08:35 pm | Updated 08:35 pm IST - Washington

A worker inspects labels on vials containing H1N1 flu vaccine during production in Beijing.

A worker inspects labels on vials containing H1N1 flu vaccine during production in Beijing.

The discovery of how a vital immune cell recognises dead and damaged body cells could open the way to next-gen vaccines that are more effective and have fewer side-effects.

Scientists from the Walter and Eliza Hall Institute have identified, for the first time, how a protein found on the surface of immune cells called dendritic cells recognises dangerous damage and trauma that could signify infection.

Dendritic cells are critical for raising an alarm about the presence of foreign invaders in the body such as viruses, bacteria and parasites as well as tumour cells and other dead or damaged cells, the journal Immunity reported.

Also known as antigen-presenting cells, they digest and present molecules from damaged cells to other immune cells that recognise foreign invaders and launch an immune response, said a university statement.

The research was a collaborative effort involving a team of immunologists, protein chemists and structural biologists, led by Mireille Lahoud, Jian-Guo Zhang, Peter Czabotar and Ken Shortman from Eliza Hall.

Lahoud said the study demonstrated that the immune system has evolved a very clever way of detecting damaged and dead cells to help promote an immune response.

Lahoud said that the finding could develop or increase the efficacy of vaccines for diseases that do not currently have good preventive options, such as malaria or HIV.

“There is also the possibility that the system could be used to develop therapeutic vaccines for treating diseases, such as some forms of cancer, as well as for preventing them,” Lahoud added.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.